Overall: AdvaMed believes that the current issues in MDR/IVDR implementation are best addressed through application of both short-term measures, to be implemented as soon as possible, ideally this year, in combination with longer-term measures, as outlined in these two papers: medtech-europe_mdr_ivdr_leaflet_four-urgent-targeted-measures-1.pdf; joint-discussion-paper-on-future-governance-of-medical-technologies.pdf.
ADV
AdvaMed
Trade union · United States · EU Transparency Register 822761899136-02
1
position filed
in the 326 files tracked
1
legislative file
of 326 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1205 trade and business associations on this site, they rank #831 by legislative files engaged — a count of participation, not a measure of influence.
0.2
declared lobbying FTE
self-declared
< €10K
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2025
in the register since
- Register category
- Trade and business associations
- Registered as
- Advanced Medical Technology Assoc. (AdvaMed)
- Head office
- Washington, DC, United states
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track AdvaMed in PolicySpeak: request access →
Work at AdvaMed? so we know who speaks for it.
Their record over time
AdvaMed filed 1 position on 4 Oct 2025, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Is this your organization?
Everything on this page comes from AdvaMed’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.